These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11451028)

  • 21. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.
    Tian R; Koyabu N; Takanaga H; Matsuo H; Ohtani H; Sawada Y
    Pharm Res; 2002 Jun; 19(6):802-9. PubMed ID: 12134950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
    Yamasaki K; Iohara D; Oyama Y; Nishizaki N; Kawazu S; Nishi K; Kadowaki D; Taguchi K; Otagiri M; Seo H
    J Pharm Pharmacol; 2020 Mar; 72(3):356-363. PubMed ID: 31828807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity.
    Messer A; Raquet N; Lohr C; Schrenk D
    Food Chem Toxicol; 2012 Mar; 50(3-4):756-60. PubMed ID: 22155270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between grapefruit juice and cardiovascular drugs.
    Bailey DG; Dresser GK
    Am J Cardiovasc Drugs; 2004; 4(5):281-97. PubMed ID: 15449971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
    Iwanaga K; Hayashi M; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
    Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grapefruit juice ingestion significantly reduces talinolol bioavailability.
    Schwarz UI; Seemann D; Oertel R; Miehlke S; Kuhlisch E; Fromm MF; Kim RB; Bailey DG; Kirch W
    Clin Pharmacol Ther; 2005 Apr; 77(4):291-301. PubMed ID: 15903127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.
    Saito M; Hirata-Koizumi M; Matsumoto M; Urano T; Hasegawa R
    Drug Saf; 2005; 28(8):677-94. PubMed ID: 16048354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
    Fuhr U
    Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
    Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond!
    Nowack R
    Nephrology (Carlton); 2008 Jun; 13(4):337-47. PubMed ID: 18363644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes.
    Girennavar B; Poulose SM; Jayaprakasha GK; Bhat NG; Patil BS
    Bioorg Med Chem; 2006 Apr; 14(8):2606-12. PubMed ID: 16338240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of fruit juices on drug disposition: a new model for drug interactions.
    Dresser GK; Bailey DG
    Eur J Clin Invest; 2003 Nov; 33 Suppl 2():10-6. PubMed ID: 14641551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herbal modulation of P-glycoprotein.
    Zhou S; Lim LY; Chowbay B
    Drug Metab Rev; 2004 Feb; 36(1):57-104. PubMed ID: 15072439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
    Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
    Kakar SM; Paine MF; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.
    Wang E; Casciano CN; Clement RP; Johnson WW
    Pharm Res; 2001 Jun; 18(6):800-6. PubMed ID: 11474784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the grapefruit-drug interaction.
    Flanagan D
    Gen Dent; 2005; 53(4):282-5; quiz 286. PubMed ID: 16158798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of common azole antifungals with P glycoprotein.
    Wang EJ; Lew K; Casciano CN; Clement RP; Johnson WW
    Antimicrob Agents Chemother; 2002 Jan; 46(1):160-5. PubMed ID: 11751127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.
    Guo LQ; Yamazoe Y
    Acta Pharmacol Sin; 2004 Feb; 25(2):129-36. PubMed ID: 14769198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.